biotech
First Molecular-Based Lab Test to Detect Metastatic Breast Cancer, Approved by the FDA
Filed in archive Diagnostics, Methodologies and Instrumentation by ruth on July 18, 2007
First Molecular-Based Lab Test to Detect Metastatic Breast Cancer, Approved by the FDA
Now breast cancer patients may be able to forgo an invasive procedure to determine if their cancer has metastasized or spread in other parts of the body.

A Johnson & Johnson company - Veridex - has developed and manufactured a molecular-based lab test that will determine metastatic breast cancer: the GeneSearchâ„¢ Breast Lymph Node (BLN) Assay.

The good news is that, the FDA has just approved this test.

According to Daniel Schultz, M.D., director of the FDA's Center for Devices and Radiological Health:

"The GeneSearch BLN Assay offers a new approach to sentinel node testing. Results of this rapid test are available while patients are on the operating table, providing a way for some women to avoid a second operation."


Find more details from the full report.



Permalink: First Molecular-Based Lab Test to Detect Metastatic Breast Cancer, Approved by the FDA
Tags: GeneSearchâ„¢  BLN  Assay  metastatic  breast  cancer  biotech  breast+cancer 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/81405
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for First Molecular-Based Lab Test to Detect Metastatic Breast Cancer, Approved by the FDA:

  • Currently 7.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.50 out of 4 vote(s) cast.
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!